Description
The inventors have discovered a novel application of a clinically used drug, namely the second-generation sulfonylurea glyburide as a protectant against lethal ionizing radiation. Glyburide and pharmacologically related chemicals may be used to protect cells and organisms, including humans, against the harmful effects caused by exposure to ionizing radiation from therapeutic, accidental or terroristic use.
IP Status
https://patents.google.com/patent/US8883852B2
